TrialStat Launches SRS 4.0 with Enhanced Features Focused on Reviewer Collaboration and Reporting

Share Article

TrialStat will unveil SRS 4.0 at the Cochrane Colloquium in Dublin, Ireland from October 23-26.

TrialStat Corporation (http://www.trialstat.com), a clinical data management on demand company, today continued to deliver enhancements to its on demand product portfolio with the launch of SRS 4.0. SRS 4.0 streamlines and automates the process of conducting systematic reviews, significantly reducing administrative costs, improving data quality, promoting collaboration and reducing the time it takes to complete a study. SRS, the world’s only commercially available systematic review platform, continues to bring industry best practices for workflow and data management to the systematic review community. Systematic reviews are a comprehensive analysis of academic research usually conducted prior to a clinical trial.

Used by some of the world’s largest academic research institutions, SRS 4.0 introduces new features that enhance and facilitate reviewer collaboration, reference management and overall study performance, while continuing to provide robust study auditability, reproducibility and transparency mandated by the systematic review community. The launch of SRS 4.0 follows closely on the heals of the October 5th launch of TrialStat’s ClinicalAnalytics 4.0, the company’s on demand EDC solution for clinical research.

“The new features in SRS 4.0 are based on the tremendous feedback we have received from the user community,” said Peter O’Blenis, Vice President Product Development, TrialStat. “TrialStat will continue to work with SRS users to ensure they have the most efficient tools possible to deliver high quality, transparent reviews quickly and cost effectively.”

New features of SRS 4.0 include the following:

  •     Public portal for published results and discussion;
  •     Microsoft® Word integration;
  •     Secure shared discussion forums; and,
  •     Overall speed increase of 25 percent.

TrialStat will demonstrate SRS 4.0 at the Cochrane Colloquium from October 23-26. Details are the following for Cochrane attendees:

When: October 23-26 – 9:00am to 5:00pm

Where: Burlington Hotel, the Hebert Room

Booth location: First left corner of the Herbert Room’s concourse entrance

SRS 4.0 will be available for customers on October 23.

ABOUT TRIALSTAT

Headquartered in Ottawa, Canada, TrialStat is a privately held company that delivers clinical data management on demand by combining its full suite of data management services with the company’s software as a service products. CA 4.0 is a robust and scaleable EDC on demand solution used by leading commercial and academic clinical research organizations. SRS 4.0™ automates systematic reviews using real-time collaboration and management tools to achieve transparent, auditable and reproducible results quickly and cost-effectively. For more information, please visit us at http://www.trialstat.com.

ClinicalAnalytics 4.0 and SRS 4.0 are registered trademarks of TrialStat Corporation.

Microsoft is a registered trademark of Microsoft Corporation.

For media inquiries, please contact:

Kathryn Schwab

Media Relations, TrialStat

613-858-4407

Shelley Mullins

Media Relations, TrialStat

613-866-8803

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kathryn Schwab
Visit website

Media